Daniels P, Noe GF, Mayberry R. Barriers to prenatal care among black women of low socioeconomic status. Am J Health Behav 2006;30(2):188–198.

Fleming NS, Herrin J, Roberts W, Couch C, Ballard DJ. Evaluation of patient-centeredness and timeliness quality measures in a primary care network: a baseline analysis and power assessment for detection of the effects of the implementation of an electronic health record. Proc (Bayl Univ Med Cent) 2006;19(4):314–319.

Fullerton C, Aponte P, Hopkins R III, Bragg D, Ballard DJ. Lessons learned from pilot site implementation of an ambulatory electronic health record. Proc (Bayl Univ Med Cent) 2006;19(4):303–310.

Hamilton C, Filardo G. The dangers of categorizing body mass index. Eur Heart J 2006;27(23):2903–2904.

Herrin J, Nicewander DA, Hollander PA, Couch CE, Winter FD Jr, Haydar ZR, Warren SS, Ballard DJ. Effectiveness of diabetes resource nurse case management and physician profiling in a fee-for-service setting: a cluster randomized trial. Proc (Bayl Univ Med Cent) 2006;19(2):95–102.

Mayberry RM, Nicewander DA, Qin H, Ballard DJ. Improving quality and reducing inequities: a challenge in achieving best care. Proc (Bayl Univ Med Cent) 2006;19(2):103–118.

Vistamehr S, Shelsta HN, Palmisano PC, Filardo G, Bashford K, Chaudhri K, Forster SH, Shafranov G, Bruce Shields M. Glaucoma screening in a high-risk population. J Glaucoma 2006;15(6):534–540.

Hepatology

Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Post AB, Redfield RR, Davis GL, Neumann AU, Osborn BL, Freimuth WW, Subramanian GM. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy. Antivir Ther 2006;11(1):35–45.

Davis GL. Hepatitis C. In Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff’s Diseases of the Liver, 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2006:805–861.

Davis GL. Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills? Liver Transpl 2006;12(9):1317–1319.

Davis GL. New therapies: oral inhibitors and immune modulators. Clin Liver Dis 2006;10(4):867–880.

Davis GL. Prevention and treatment of viral hepatitis. In Wolfe MM, Davis GL, Farraye FA, Giannella R, Malagelada JR, Steer ML, eds. Therapy of Digestive Disorders, 2nd ed. Philadelphia: Saunders, 2006:502–524.

Davis GL. Tailoring antiviral therapy in hepatitis C. Hepatology 2006;43(5):909–911.

Davis GL. The challenge of progressive hepatitis C following liver transplantation. Liver Transpl 2006;12(1):19–21.

Davis GL. Thoughts on nutrition and liver disease. Nutr Clin Pract 2006;21(3):243–244.

Lepe R, Layden-Almer JE, Layden TJ, Cotler S. Ethnic differences in the presentation of chronic hepatitis C. J Viral Hepat 2006;13(2):116–120.

Perrillo RP. Therapy of hepatitis B—viral suppression or eradication? Hepatology 2006;43(2 Suppl 1):S182–S193.

Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S. Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol 2006;4(2):233–248.

Saadeh S. Non-alcoholic fatty liver disease. In Wolfe MM, Davis GL, Farraye FA, Giannella R, Malagelada JR, Steer ML, eds. Therapy of Digestive Disorders, 2nd ed. Philadelphia: Saunders, 2006:551–564.

O’Brien JC Jr. History of tumor site conferences at Baylor University Medical Center. Proc (Bayl Univ Med Cent) 2006;19(2):130–131.

Ramsay MAE. John Snow, MD: anaesthetist to the Queen of England and pioneer epidemiologist. Proc (Bayl Univ Med Cent) 2006;19(1):24–28.

Rohrich RJ. The 10-year American Society of Plastic Surgeons’ history update. Plast Reconstr Surg 2006;118(5 Suppl):1S.

Stone MJ. History of site-tumor conferences at Baylor Sammons Cancer Center [reader comment]. Proc (Bayl Univ Med Cent) 2006;19(3):249.